Nemtabrutinib Recruiting Phase 3 Trials for Small Lymphocytic Leukemia (SLL) / Chronic Lymphocytic Leukemia Treatment

Indications	Status	Purpose	Phase
DBCOND0117330 (Small Lymphocytic Leukemia (SLL)) DBCOND0028332 (Chronic Lymphocytic Leukemia)	Recruiting	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT05624554	A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)	Bendamustine (DB06769) Cyclophosphamide (DB00531) Fludarabine (DB01073) Nemtabrutinib (DB18866) Rituximab (DB00073)